Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs TIVA in Pediatric Congenital Heart Surgery
NCT03630796Phase 4Unknown
- Sponsor
- Instituto do Coração
- Start
- Aug 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sevoflurane in congenital heart defects (CHD) (2 arms), sponsored by Instituto do Coração. Primary endpoint: Serum levels curve of troponin I at 72 hours. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
congenital heart defects (CHD)
Beyond the preview
Go deeper on NCT03630796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03630796.